The ophthalmic artificial intelligence-assisted diagnosis market size has grown rapidly in recent years. It will grow from $2.17 billion in 2025 to $2.57 billion in 2026 at a compound annual growth rate (CAGR) of 18.5%. The growth in the historic period can be attributed to increasing adoption of digital imaging devices, rising prevalence of eye diseases, awareness of early diagnosis, integration of ai in clinical trials, advancements in retinal imaging technology.
The ophthalmic artificial intelligence-assisted diagnosis market size is expected to see rapid growth in the next few years. It will grow to $5.03 billion in 2030 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to growth of cloud-based ai diagnostic platforms, expansion of tele-ophthalmology services, improved ai algorithms for rare eye disorders, partnerships between ai developers and hospitals, increased adoption of predictive ophthalmology. Major trends in the forecast period include AI-based retinal imaging analysis, deep learning-powered disease detection, predictive ophthalmology models, automated patient record analysis, integration of ai with clinical workflows.
The increasing incidence of eye disorders is anticipated to drive the expansion of the ophthalmic artificial intelligence-assisted diagnosis market in the coming years. Eye disorders are medical conditions or abnormalities that affect the structure or function of the eye, potentially leading to impaired vision or compromised eye health. The prevalence of eye disorders is growing due to prolonged screen time from digital device usage, which can result in digital eye strain, dryness, and long-term vision problems from extended blue light exposure and reduced blinking frequency. Ophthalmic artificial intelligence-assisted diagnosis aids by analyzing medical images and patient data to detect, classify, and predict eye disorders with accuracy and at an early stage, facilitating timely treatment and minimizing the risk of vision loss. For example, in August 2023, the World Health Organization (WHO), a Switzerland-based United Nations agency, reported that over 2.2 billion people globally live with near or distance vision impairment - more than 1 billion of whom have preventable or untreated conditions. Refractive errors and cataracts remain the primary causes, while access to effective interventions reaches only 36% of individuals with refractive error-related impairment and just 17% of those with cataract-related impairment. Consequently, the growing prevalence of eye disorders is fueling the development of the ophthalmic artificial intelligence-assisted diagnosis market.
Companies in the ophthalmic AI-assisted diagnosis market are increasingly developing innovative solutions to improve diagnostic accuracy, enhance patient care, and provide predictive insights. One such solution is the ocular data-as-a-service platform, a digital tool that allows ophthalmologists, clinics, and AI diagnostic systems to remotely access, analyze, and share ocular data such as retinal images. This improves diagnosis, monitoring, and research. For instance, in May 2025, Topcon Healthcare Solutions Inc. introduced IDHea, a cloud-based platform designed to streamline ophthalmic diagnostics and improve patient outcomes. By offering fast and secure access to real-world and clinical ocular datasets, IDHea accelerates AI and digital health innovation. It helps researchers generate AI-driven insights to advance both eye and systemic disease care. Built on principles of fast access, safety, and transparency, IDHea facilitates personalized and proactive patient care while ensuring privacy and governance.
In May 2025, Topcon Healthcare Inc. strengthened its AI-driven ophthalmic diagnostic capabilities by acquiring RetInSight GmbH. This acquisition supports the company's objective of advancing global eye care through intelligent diagnostic solutions. RetInSight GmbH, an Austrian medtech company, specializes in AI-assisted ophthalmic diagnostics. With this acquisition, Topcon Healthcare enhances its ability to deliver high-quality eye care, reduce costs, and improve clinical outcomes through innovations in retinal imaging.
Major companies operating in the ophthalmic artificial intelligence-assisted diagnosis market are IDx Technologies Inc., Digital Diagnostics Inc., AEYE Health Inc., Eyenuk Inc., OphtAI, Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd., Neurodynamics Solutions Inc.
North America was the largest region in the ophthalmic artificial intelligence-assisted diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmic artificial intelligence-assisted diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ophthalmic artificial intelligence-assisted diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the ophthalmic ai-assisted diagnosis market by increasing the import costs of imaging devices, ai-enabled software, and high-resolution cameras. This has particularly affected hospitals, clinics, and imaging centers in Asia-Pacific and Europe. Segments relying on imported retinal cameras and ai software are most impacted. However, tariffs have encouraged local software development and domestic production of imaging systems, which may improve supply chain resilience and reduce long-term costs.
The ophthalmic artificial intelligence-assisted diagnosis market research report is one of a series of new reports that provides ophthalmic artificial intelligence-assisted diagnosis market statistics, including ophthalmic artificial intelligence-assisted diagnosis industry global market size, regional shares, competitors with a ophthalmic artificial intelligence-assisted diagnosis market share, detailed ophthalmic artificial intelligence-assisted diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic artificial intelligence-assisted diagnosis industry. This ophthalmic artificial intelligence-assisted diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ophthalmic artificial intelligence-assisted diagnosis refers to the use of AI technologies to analyze eye-related medical data, such as retinal images or patient records, for the detection, diagnosis, or monitoring of eye diseases. It combines algorithms such as machine learning and deep learning with imaging and clinical data to support faster, more accurate, and automated decision-making in ophthalmology.
The primary types of ophthalmic AI-assisted diagnosis systems are cloud-based and on-premises. Cloud-based systems are hosted on remote servers and accessed via the internet. Technologies involved include deep learning, machine learning, natural language processing (NLP), computer vision, and others. These systems are applied in settings such as hospitals, clinics, and imaging centers.
The ophthalmic artificial intelligence-assisted diagnosis market includes revenues earned by entities by providing services such as technical support and maintenance, clinical trial support, training and consultation, data management, and annotation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ophthalmic artificial intelligence-assisted diagnosis market also includes sales of wearable eye-tracking devices, retinal scanners, AI-enabled slit-lamp imaging devices, and portable artificial intelligence ophthalmic diagnostic kits. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The ophthalmic artificial intelligence-assisted diagnosis market size is expected to see rapid growth in the next few years. It will grow to $5.03 billion in 2030 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to growth of cloud-based ai diagnostic platforms, expansion of tele-ophthalmology services, improved ai algorithms for rare eye disorders, partnerships between ai developers and hospitals, increased adoption of predictive ophthalmology. Major trends in the forecast period include AI-based retinal imaging analysis, deep learning-powered disease detection, predictive ophthalmology models, automated patient record analysis, integration of ai with clinical workflows.
The increasing incidence of eye disorders is anticipated to drive the expansion of the ophthalmic artificial intelligence-assisted diagnosis market in the coming years. Eye disorders are medical conditions or abnormalities that affect the structure or function of the eye, potentially leading to impaired vision or compromised eye health. The prevalence of eye disorders is growing due to prolonged screen time from digital device usage, which can result in digital eye strain, dryness, and long-term vision problems from extended blue light exposure and reduced blinking frequency. Ophthalmic artificial intelligence-assisted diagnosis aids by analyzing medical images and patient data to detect, classify, and predict eye disorders with accuracy and at an early stage, facilitating timely treatment and minimizing the risk of vision loss. For example, in August 2023, the World Health Organization (WHO), a Switzerland-based United Nations agency, reported that over 2.2 billion people globally live with near or distance vision impairment - more than 1 billion of whom have preventable or untreated conditions. Refractive errors and cataracts remain the primary causes, while access to effective interventions reaches only 36% of individuals with refractive error-related impairment and just 17% of those with cataract-related impairment. Consequently, the growing prevalence of eye disorders is fueling the development of the ophthalmic artificial intelligence-assisted diagnosis market.
Companies in the ophthalmic AI-assisted diagnosis market are increasingly developing innovative solutions to improve diagnostic accuracy, enhance patient care, and provide predictive insights. One such solution is the ocular data-as-a-service platform, a digital tool that allows ophthalmologists, clinics, and AI diagnostic systems to remotely access, analyze, and share ocular data such as retinal images. This improves diagnosis, monitoring, and research. For instance, in May 2025, Topcon Healthcare Solutions Inc. introduced IDHea, a cloud-based platform designed to streamline ophthalmic diagnostics and improve patient outcomes. By offering fast and secure access to real-world and clinical ocular datasets, IDHea accelerates AI and digital health innovation. It helps researchers generate AI-driven insights to advance both eye and systemic disease care. Built on principles of fast access, safety, and transparency, IDHea facilitates personalized and proactive patient care while ensuring privacy and governance.
In May 2025, Topcon Healthcare Inc. strengthened its AI-driven ophthalmic diagnostic capabilities by acquiring RetInSight GmbH. This acquisition supports the company's objective of advancing global eye care through intelligent diagnostic solutions. RetInSight GmbH, an Austrian medtech company, specializes in AI-assisted ophthalmic diagnostics. With this acquisition, Topcon Healthcare enhances its ability to deliver high-quality eye care, reduce costs, and improve clinical outcomes through innovations in retinal imaging.
Major companies operating in the ophthalmic artificial intelligence-assisted diagnosis market are IDx Technologies Inc., Digital Diagnostics Inc., AEYE Health Inc., Eyenuk Inc., OphtAI, Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd., Neurodynamics Solutions Inc.
North America was the largest region in the ophthalmic artificial intelligence-assisted diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmic artificial intelligence-assisted diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ophthalmic artificial intelligence-assisted diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the ophthalmic ai-assisted diagnosis market by increasing the import costs of imaging devices, ai-enabled software, and high-resolution cameras. This has particularly affected hospitals, clinics, and imaging centers in Asia-Pacific and Europe. Segments relying on imported retinal cameras and ai software are most impacted. However, tariffs have encouraged local software development and domestic production of imaging systems, which may improve supply chain resilience and reduce long-term costs.
The ophthalmic artificial intelligence-assisted diagnosis market research report is one of a series of new reports that provides ophthalmic artificial intelligence-assisted diagnosis market statistics, including ophthalmic artificial intelligence-assisted diagnosis industry global market size, regional shares, competitors with a ophthalmic artificial intelligence-assisted diagnosis market share, detailed ophthalmic artificial intelligence-assisted diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic artificial intelligence-assisted diagnosis industry. This ophthalmic artificial intelligence-assisted diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ophthalmic artificial intelligence-assisted diagnosis refers to the use of AI technologies to analyze eye-related medical data, such as retinal images or patient records, for the detection, diagnosis, or monitoring of eye diseases. It combines algorithms such as machine learning and deep learning with imaging and clinical data to support faster, more accurate, and automated decision-making in ophthalmology.
The primary types of ophthalmic AI-assisted diagnosis systems are cloud-based and on-premises. Cloud-based systems are hosted on remote servers and accessed via the internet. Technologies involved include deep learning, machine learning, natural language processing (NLP), computer vision, and others. These systems are applied in settings such as hospitals, clinics, and imaging centers.
The ophthalmic artificial intelligence-assisted diagnosis market includes revenues earned by entities by providing services such as technical support and maintenance, clinical trial support, training and consultation, data management, and annotation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ophthalmic artificial intelligence-assisted diagnosis market also includes sales of wearable eye-tracking devices, retinal scanners, AI-enabled slit-lamp imaging devices, and portable artificial intelligence ophthalmic diagnostic kits. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Characteristics
3. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Supply Chain Analysis
4. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Trends and Strategies
5. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Analysis of End Use Industries
7. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Total Addressable Market (TAM) Analysis for the Market
9. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Segmentation
10. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Regional and Country Analysis
11. Asia-Pacific Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
12. China Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
13. India Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
14. Japan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
15. Australia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
16. Indonesia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
17. South Korea Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
18. Taiwan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
19. South East Asia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
20. Western Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
21. UK Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
22. Germany Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
23. France Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
24. Italy Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
25. Spain Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
26. Eastern Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
27. Russia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
28. North America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
29. USA Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
30. Canada Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
31. South America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
32. Brazil Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
33. Middle East Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
34. Africa Ophthalmic Artificial Intelligence-Assisted Diagnosis Market
36. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Competitive Landscape and Company Profiles
37. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Other Major and Innovative Companies
40. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ophthalmic artificial intelligence-assisted diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ophthalmic artificial intelligence-assisted diagnosis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ophthalmic artificial intelligence-assisted diagnosis market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Cloud-Based; On-Premises2) By Technology: Deep Learning; Machine Learning; Computer Vision; Other Technologies
3) By Application: Hospital; Clinic; Imaging Centre
Subsegments:
1) By Cloud-Based: Public Cloud; Private Cloud; Hybrid Cloud2) By On-Premises: Local Server Deployment; Enterprise Data Center Deployment; Private Network Deployment
Companies Mentioned: IDx Technologies Inc.; Digital Diagnostics Inc.; AEYE Health Inc.; Eyenuk Inc.; OphtAI; Oivi Tech Private Limited; Altris Inc.; JuneBrain Inc.; Mediwhale Inc.; MONA.health BV; Remidio Innovative Solutions Pvt. Ltd.; Retinalyze System A/S; Retmarker; RetinaRisk; Ikerian AG; VoxelCloud Inc.; Visulytix Ltd.; Aiforia Technologies Plc; DeepTek Inc.; EyRIS Pte Ltd.; Neurodynamics Solutions Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Ophthalmic Artificial Intelligence-Assisted Diagnosis market report include:- IDx Technologies Inc.
- Digital Diagnostics Inc.
- AEYE Health Inc.
- Eyenuk Inc.
- OphtAI
- Oivi Tech Private Limited
- Altris Inc.
- JuneBrain Inc.
- Mediwhale Inc.
- MONA.health BV
- Remidio Innovative Solutions Pvt. Ltd.
- Retinalyze System A/S
- Retmarker
- RetinaRisk
- Ikerian AG
- VoxelCloud Inc.
- Visulytix Ltd.
- Aiforia Technologies Plc
- DeepTek Inc.
- EyRIS Pte Ltd.
- Neurodynamics Solutions Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.57 Billion |
| Forecasted Market Value ( USD | $ 5.03 Billion |
| Compound Annual Growth Rate | 18.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
